Clinical trials: sponsored by Baylor Research Institute
Malignant Melanoma Stage IV
Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients
The purpose of this study is to determine whether the combination of chemotherapy (Cyclophosphamide) and CD34-DC vaccines results in the improved rate of clinical responses for stage IV melanoma patients.
- Trial name
- NCT00722098
- Testing
- DC Vaccine & Cyclophosphamide
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- Baylor Research Institute
Malignant Melanoma Stage IV
Combined Modality Treatment for Patients With Stage IV Melanoma
The purpose of this study is to test a combined treatment using cyclophosphamide and a novel dendritic cell vaccine in patients with Stage IV melanoma.
- Trial name
- NCT00313235
- Testing
- DC Vaccine and Cyclophosphamide
- Where
- United States
- Volunteers
- 41 people
- Sponsor
- Baylor Research Institute
Leukemia, Myelodysplastic Syndrome
Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen
The purpose of this study is to determine whether Clofarabine in combination with Busulfan is effective as a preparative transplant regimen for the treatment of leukemia and myelodysplastic syndromes
- Trial name
- NCT00852163
- Testing
- Clofarabine with Busulfan
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Baylor Research Institute